Sort

Search

01/02/2026 Bleximenib in Combination with Intensive Chemotherapy: A phase 1b Study in Patients with Newly Diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 Alterations
Döhner, H, Schuh, AC, Recher, C, O'Nions, J, Aldoss, I, Piérola, AA, Allred, AJ, Alonso-Dominguez, JM, Barreyro, L, Bories, P, Daskalakis, N, Della Porta, MG, D'Souza, A, Dugan, J, Esteve, J, Fathi, AT, Ferrante, L, Gaj, S, Garciaz, S, Diaz, AG, Salamero, O, Guttke, C, Gyan, E, Hiebert, B, Jabbour, E, Jentzsch, M, Kantarjian, HM, Konopleva, M, Krönke, J, Hütter-Krönke, ML, Loefgren, C, Lomas, O, Mancini, V, Mantzaris, I, Morillo, D, Packman, K, Papayannidis, C, Philippar, U, Platzbecker, U, Paniagua, SG, Sackey, N, Sauer, T, Shastri, PN, Searle, E, Tovar, N, Trancucci, D, Vallet, N, Vaughan, L, Vyas, P, Wei, AH, Rölling, C. Bleximenib in Combination with Intensive Chemotherapy: A phase 1b Study in Patients with Newly Diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 Alterations. Transplantation And Cellular Therapy. 2026; 32(2)DOI:. PMID:. IF:4.400(Q1/1D).
01/02/2026 Outcomes of de novo primary central nervous system lymphoma using the MATRix regimen for induction followed by thiotepa-based conditioning: a GELTAMO analysis
Lopez-Pereira, P, Domínguez, SR, Martin-Moro, F, Caballero, AC, García, AL, Benito, BD, Sarto, MF, Vicente, FD, Marín, JL, Marino, SP, Jiménez-Ubieto, A, Cabirta, A, Gutiérrez, NC, Chulvi, MJL, Puyuelo, A, Prat, AM, Coello, AP, García-Lerma, E, Vilchez, SM. Outcomes of de novo primary central nervous system lymphoma using the MATRix regimen for induction followed by thiotepa-based conditioning: a GELTAMO analysis. BONE MARROW TRANSPLANTATION. 2026; 61(2)DOI:10.1038/s41409-025-02772-2. PMID:41310181. IF:5.200(Q1/1D).
01/02/2026 Phase II Interim Results for Rapcabtagene Autoleucel (YTB323) in Patients with First-Line, High-Risk Large B-cell Lymphoma
Westin, J, Chavez, JC, Schuster, SJ, Vucinic, V, Young, PA, Johnson, PC, Bramanti, S, Rambaldi, A, Meijide, JB, Kato, K, Sancho, JM, Kwon, M, Solano, C, Fleming, S, Dahiya, S, García-Sancho, AM, Ramos, PM, Pearson, D, Diallo, S, Zia, A, Segura, E, Masood, A, Barba, P. Phase II Interim Results for Rapcabtagene Autoleucel (YTB323) in Patients with First-Line, High-Risk Large B-cell Lymphoma. Transplantation And Cellular Therapy. 2026; 32(2)DOI:. PMID:. IF:4.400(Q1/1D).
01/02/2026 The role of artificial intelligence in predicting graft survival in kidney transplantation: a systematic review
Di Bello, F, Gallioli, A, Pecoraro, A, Prudhomme, T, Piana, A, Marco, BB, Haberal, HB, Dönmez, MI, Lopez-Abad, A, Cannoletta, D, Mancon, S, Guirado, L, Facundo, C, Kanashiro, AK, Gavrilov, P, Rodriguez-Faba, O, Gaya, JM, Breda, A, Territo, A. The role of artificial intelligence in predicting graft survival in kidney transplantation: a systematic review. Minerva Urology And Nephrology. 2026; 78(1)DOI:10.23736/S2724-6051.25.06559-0. PMID:41697205. IF:4.200(Q1/2D).
01/02/2026 Risk factors associated with inadequacy of empirical treatment in patients with sepsis and bacteremia attended in an emergency department
Motos-Bescós, M, Ruiz-Ramos, J, Agra-Montava, I, Moliné-Pareja, A, Palacio-Alvarez, P, Villarejo-Jiménez, A, Pomar-Solchaga, V. Risk factors associated with inadequacy of empirical treatment in patients with sepsis and bacteremia attended in an emergency department. Revista Espanola de Quimioterapia. 2026; 39(1)DOI:10.37201/req/101.2025. PMID:41521957. IF:2.200(Q3/6D).
01/02/2026 LONG-TERM CLINICAL AND FUNCTIONAL EVOLUTION IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND DAYTIME SLEEPINESS TREATED WITH CPAP: RESULTS FROM THE HYPNOSA COHORT STUDY
Lázaro, AR, Mediano, O, Cano, I, Egea, C, Monasterio, M, Muñoz, C, Podzamczer, I, Gonzalez, M, Grau, N, Cabriada, V, Cano, MDP, Dalmases, M, Salord, N, Castelló, C, Ramos, A, Lores, V, Arias, B, Jara, B, Ruiz, C, Horrillo, A, Romero, S, Pozuelo, L, Martinez, D, Boukichou, N, Barbé, F, de la Torre, MS. LONG-TERM CLINICAL AND FUNCTIONAL EVOLUTION IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND DAYTIME SLEEPINESS TREATED WITH CPAP: RESULTS FROM THE HYPNOSA COHORT STUDY. SLEEP MEDICINE. 2026; 138DOI:. PMID:. IF:3.400(Q2/3D).
01/02/2026 A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology
Huber, H, Montoliu-Gaya, L, Brum, WS, Vávra, J, Yakoub, Y, Weninger, H, Braun-Wohlfahrt, LS, Simrén, J, Boada, M, Ruiz, A, Cano, A, Orellana, A, Valero, S, Cañada, L, Tantinya, N, Nogales, AB, Sanz-Cartagena, P, Dittrich, A, Skoog, I, Sander-Long, M, Ballard, C, Richards, M, O'Leary, M, Clemmensen, FK, Wandall, HHD, Altomare, D, Cantoni, V, Stomrud, E, Palmqvist, S, Lleo, A, Alcolea, D, Iragui, MC, Hernandez, AS, Benejam, B, Toro, LV, Singh, A, Denkinger, MN, Simonsen, AH, Kern, S, Corbett, A, Fortea, J, Honigberg, L, Borroni, B, Hansson, O, Morató, X, Blennow, K, Zetterberg, H, Ashton, NJ. A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology. NATURE MEDICINE. 2026; 32(2)DOI:10.1038/s41591-025-04080-0. PMID:41491101. IF:50.000(Q1/1D).
01/02/2026 INTERNATIONAL RECOMMENDATIONS FOR SLEEP AND CIRCADIAN RESEARCH IN AGING AND ALZHEIMER'S DISEASE: A DELPHI CONSENSUS STUDY
André, C, Stankeviciute, L, Michaelian, JC, Antonsdottir, IM, Benca, RM, Coulthard, EJ, D'Rozario, AL, Dijk, DJ, Gimenez, S, Gorgoni, M, Leng, Y, Lucey, BP, Pase, MP, Rainey-Smith, SR, Rosenzweig, I, Spira, AP, Winer, JR, Rauchs, G, Naismith, SL. INTERNATIONAL RECOMMENDATIONS FOR SLEEP AND CIRCADIAN RESEARCH IN AGING AND ALZHEIMER'S DISEASE: A DELPHI CONSENSUS STUDY. SLEEP MEDICINE. 2026; 138DOI:. PMID:. IF:3.400(Q2/3D).
01/02/2026 followME Fabry Pathfinders real-world registry in Spain and Portugal: Cardiac and renal outcomes with migalastat in patients with Fabry disease
Azevedo, O, Ripoll-Vera, T, Aguiar, P, Torra, R, Climent-Payá, V, Camprodon-Gomez, M, de Juan-Ribera, J, Mendoza, ML, Espinosa, M, Martin, JJF, Oliveira, JP, Fortuny, E, Garcia-Pinilla, JM, Gimeno, JR, Martin, FJM, Aguinaga, A, Vaz, AL, Hiros, J, Jain, V, Rotse, BOV, Torregrosa, V. followME Fabry Pathfinders real-world registry in Spain and Portugal: Cardiac and renal outcomes with migalastat in patients with Fabry disease. MOLECULAR GENETICS AND METABOLISM. 2026; 147(2)DOI:10.1016/j.ymgme.2025.109320. PMID:. IF:3.500(Q2/4D).
01/02/2026 Analysis of trace elements and detection of microorganisms in plant-based meat alternatives: health risk assessment
González, N, Domingo, JL, Soler, S, Alvarez, M, Pavón, V, Samblas, D, Abuín, S, Calderón, J, Ramírez, B, Morral-Puigmal, C, Planell, R, Sabaté, S, Castell, V, Alcalde-Sanz, L, Nadal, M. Analysis of trace elements and detection of microorganisms in plant-based meat alternatives: health risk assessment. Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure & Risk Assessment. 2026; 43(2)DOI:10.1080/19440049.2025.2602187. PMID:41542880. IF:2.200(Q3/6D).
01/02/2026 Effectiveness of 12-months tralokinumab treatment in 124 adults with atopic dermatitis with genital involvement: final real-world data from the prospective, non-interventional, international, single-cohort trace study
Krüger-Szabo, A, Ameen, A, Serra-Baldrich, E, Armstrong, AW, Festini, T, Vinther, F, Vittrup, I, Wiseman, MC. Effectiveness of 12-months tralokinumab treatment in 124 adults with atopic dermatitis with genital involvement: final real-world data from the prospective, non-interventional, international, single-cohort trace study. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2026; 24DOI:. PMID:. IF:3.800(Q1/2D).
01/02/2026 The housing rights crisis and its impact on health
Borrell, C, Carrere, J, Pérez, K. The housing rights crisis and its impact on health. Gaceta Sanitaria. 2026; 40DOI:10.1016/j.gaceta.2026.102567. PMID:41702336. IF:1.500(Q3/7D).
01/02/2026 Patients' Needs and Expectations for the Application of Prevention of Drug-related Problems Prevention Programs
Llopis, AV, Ruiz-Ramos, J, Díaz, AP, Campmany, MP, Alvarez, AB, Sampol-Mayol, C, Juanes-Borrego, A. Patients' Needs and Expectations for the Application of Prevention of Drug-related Problems Prevention Programs. Journal Of Research In Pharmacy Practice. 2026; 15(1)DOI:10.4103/jrpp.jrpp_32_25. PMID:41969590. IF:(Q/D).
01/02/2026 Low-severity emergencies in older patients: clarifications to improve validity and applicability
Montava, IA, Ontiveros, HH, Rizzi, M. Low-severity emergencies in older patients: clarifications to improve validity and applicability. EMERGENCIAS. 2026; 38(1)DOI:10.55633/s3me/087.2025. PMID:41575431. IF:6.300(Q1/1D).
01/02/2026 Careful ventilation in acute respiratory distress syndrome: the protocol of the CAVIARDS international multicentre randomised basket trial
Coudroy, R, Telias, I, Jonkman, A, Thille, AW, Diehl, J, Péron, N, Ko, MT, Bourion, AA, Tiribelli, N, Fredes, S, Gutiérrez, M, Bruno, AM, Vasquez, DN, Pratto, RA, Plotnikow, GA, Bianchini, F, Accoce, M, Dorado, J, Spadaro, S, La Rosa, R, Prat, G, Bailly, P, Delbove, A, Pacheco-Reyes, A, Roca, O, Kuteifan, K, Rouzé, A, Grieco, DL, Izura-Gómez, M, Mancebo, J, Sigaud, F, Terzi, N, Saccheri, C, Dellamonica, J, Richecoeur, J, Setten, M, Rauseo, M, Beloncle, F, Repusseau, B, Rozé, H, Tran-Van, D, Damiani, F, Slama, M, Kaufman, DA, Maraffi, T, Goligher, EC, Plantefève, G, Determann, R, Giamou, M, Pham, T, Del Sorbo, L, Keown-Stoneman, CDG, Nisenbaum, R, Thorpe, K, Piraino, T, Chen, L, Jüni, P, Ferguson, ND, Slutsky, AS, Brochard, L. Careful ventilation in acute respiratory distress syndrome: the protocol of the CAVIARDS international multicentre randomised basket trial. BMJ Open. 2026; 16(2)DOI:10.1136/bmjopen-2025-115775. PMID:41730551. IF:2.300(Q2/3D).
01/02/2026 Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison
Chovatiya, R, Armstrong, A, Kircik, L, Puig, L, Kirchhof, MG, Torres, T, Binamer, Y, Duarte, G, Akmaz, B, Dossenbach, M, Gallo, G, Yang, C, Seminario-Vidal, L, Ding, YX, Silverberg, JI. Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison. Dermatology and Therapy. 2026; 16(2)DOI:10.1007/s13555-025-01620-x. PMID:41420795. IF:4.200(Q1/1D).
01/02/2026 Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study
Torres, T, Sood, S, Yilmaz, O, Vender, RB, Prajapati, VH, Puig, L, Megna, M, Marzano, AV, Gisondi, P, Carrascosa, JM, Dauden, E, Llamas-Velasco, M, Balato, A, Leal, BG, Prignano, F, Bellinato, F, Silvi, G, Di Brizzi, EV, Potestio, L, Carrera, CG, López-Ferrer, A, Del-Alcazar, E, Mufti, A, Maul, LV, Piaserico, S, Maul, JT, Yeung, JS. Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study. Dermatology and Therapy. 2026; 16(2)DOI:10.1007/s13555-026-01653-w. PMID:41575604. IF:4.200(Q1/1D).
01/02/2026 Efficacy and Safety of Risankizumab in Psoriatic Patients With a History of Malignancy: Real-World Evidence From a Multicentre Spanish Study
Díaz, JM, Alarcon, SS, Romero, IB, Apetrei, LS, Fernández, LG, Ramos, FJM, Alberola, FT, Martínez, MAB, Ruiz, AB, Rodríguez, OB, Ruiz-Villaverde, R, González, MC, Farrés, MF, Puchades, AM, Tapial, JM, Rull, EV, Montalvo, SM. Efficacy and Safety of Risankizumab in Psoriatic Patients With a History of Malignancy: Real-World Evidence From a Multicentre Spanish Study. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2026; 67(1)DOI:10.1111/ajd.70012. PMID:41347368. IF:1.800(Q3/6D).
01/02/2026 Management of Obesity in Psoriasis Consultations
Nicolau, J, López-Ferrer, A, de la Cueva, P. Management of Obesity in Psoriasis Consultations. Dermatology and Therapy. 2026; 16(2)DOI:10.1007/s13555-026-01664-7. PMID:41627722. IF:4.200(Q1/1D).
01/02/2026 Intrahepatic Versus Extrahepatic Biliary Tree Cysts: Outcomes after Surgical Resection in a Multicentric Study
Ferrari, C, D'Ambrosio, GM, Martin, B, Romera, AG, Molina, V, Griseri, G, Moral, A, Sánchez-Cabús, S. Intrahepatic Versus Extrahepatic Biliary Tree Cysts: Outcomes after Surgical Resection in a Multicentric Study. Journal of Laparoendoscopic & Advanced Surgical Techniques. 2026; 36(2)DOI:10.1177/10926429251408365. PMID:41467982. IF:1.100(Q3/7D).